Related references
Note: Only part of the references are listed.Progesterone Receptor A Stability Is Mediated by Glycogen Synthase Kinase-3β in the Brca1-deficient Mammary Gland
Shaohui Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
KIBRA exhibits MST-independent functional regulation of the Hippo signaling pathway in mammals
S. Moleirinho et al.
ONCOGENE (2013)
YAP Promotes Breast Cell Proliferation and Survival Partially through Stabilizing the KLF5 Transcription Factor
Xu Zhi et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Characterisation of amplification patterns and target genes at chromosome 11q13 in CCND1-amplified sporadic and familial breast tumours
Karolina Holm et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Loss of Yes-associated protein (YAP) expression is associated with estrogen and progesterone receptors negativity in invasive breast carcinomas
Rozina Tufail et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Yes-associated protein promotes tumour development in luminal epithelial derived breast cancer
Xiaodan Wang et al.
EUROPEAN JOURNAL OF CANCER (2012)
Identification, basic characterization and evolutionary analysis of differentially spliced mRNA isoforms of human YAP1 gene
Christian J. Gaffney et al.
GENE (2012)
LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker
Dahu Chen et al.
NATURE MEDICINE (2012)
The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain
John M. Lamar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The YAP and TAZ transcription co-activators: Key downstream effectors of the mammalian Hippo pathway
Wanjin Hong et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2012)
Effects of cyclin D1 gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC study
Katja Lundgren et al.
BREAST CANCER RESEARCH (2012)
YAP is a candidate oncogene for esophageal squamous cell carcinoma
Tomoki Muramatsu et al.
CARCINOGENESIS (2011)
Breast Cancer 2 Gene expression profiling in breast cancer: classification, prognostication, and prediction
Jorge S. Reis-Filho et al.
LANCET (2011)
The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene
X. Zhang et al.
ONCOGENE (2011)
Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer
Yang Wang et al.
CANCER SCIENCE (2010)
Structural basis of YAP recognition by TEAD4 in the Hippo pathway
Liming Chen et al.
GENES & DEVELOPMENT (2010)
EPIGENETICS AND GENETICS A census of amplified and overexpressed human cancer genes
Thomas Santarius et al.
NATURE REVIEWS CANCER (2010)
Both TEAD-Binding and WW Domains Are Required for the Growth Stimulation and Oncogenic Transformation Activity of Yes-Associated Protein
Bin Zhao et al.
CANCER RESEARCH (2009)
Nuclear CDKs Drive Smad Transcriptional Activation and Turnover in BMP and TGF-β Pathways
Claudio Alarcon et al.
CELL (2009)
The removal of multiplicative, systematic bias allows integration of breast cancer gene expression datasets - improving meta-analysis and prediction of prognosis
Andrew H. Sims et al.
BMC MEDICAL GENOMICS (2008)
Hypoxia-Inducible Factor-2α Correlates to Distant Recurrence and Poor Outcome in Invasive Breast Cancer
Karolina Helczynska et al.
CANCER RESEARCH (2008)
Yes-associated protein (YAP) functions as a tumor suppressor in breast
M. Yuan et al.
CELL DEATH AND DIFFERENTIATION (2008)
Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling
Mitsunori Ota et al.
DEVELOPMENT (2008)
The TEAD/TEF family protein scalloped mediates transcriptional output of the hippo growth-regulatory pathway
Shian Wu et al.
DEVELOPMENTAL CELL (2008)
The TEAD/TEF family of transcription factor scalloped mediates hippo signaling in organ size control
Lei Zhang et al.
DEVELOPMENTAL CELL (2008)
TEAD mediates YAP-dependent gene induction and growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2008)
Expression of Yes-associated protein in common solid tumors
Angela A. Steinhardt et al.
HUMAN PATHOLOGY (2008)
Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer
Elton Rexhepaj et al.
BREAST CANCER RESEARCH (2008)
Gene products of chromosome 11q and their association with CCND1 gene amplification and tamoxifen resistance in premenopausal breast cancer
Katja Lundgren et al.
BREAST CANCER RESEARCH (2008)
Reversal of the estrogen receptor-negative phenotype in breast cancer and restoration of antiestrogen response
Jill Bayliss et al.
CLINICAL CANCER RESEARCH (2007)
RASSRA elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the P73 tumor suppressor protein
David Matallanas et al.
MOLECULAR CELL (2007)
Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series
Christine Desmedt et al.
CLINICAL CANCER RESEARCH (2007)
High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer
Suet F. Chin et al.
GENOME BIOLOGY (2007)
Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist
Aleksandra Jovanovic Poole et al.
SCIENCE (2006)
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies
Koei Chin et al.
CANCER CELL (2006)
Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer
Anna V. Ivshina et al.
CANCER RESEARCH (2006)
WW domain binding protein-2, an E6-associated protein interacting protein, acts as a coactivator of estrogen and progesterone receptors
Sarath C. Dhananjayan et al.
MOLECULAR ENDOCRINOLOGY (2006)
Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon
Michael Overholtzer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach
Lars Zender et al.
CELL (2006)
Gene expression profiling in breast cancer: Understanding the molecular basis of histologic grade to improve prognosis
C Sotiriou et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Pathology parameters and adjuvant tamoxifen response in a randomised premenopausal breast cancer trial
K Jirström et al.
JOURNAL OF CLINICAL PATHOLOGY (2005)
Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts
Y Pawitan et al.
BREAST CANCER RESEARCH (2005)
Two years of adjuvant tamoxifen in premenopausal patients with breast cancer: a randomised, controlled trial with long-term follow-up
L Ryden et al.
EUROPEAN JOURNAL OF CANCER (2005)
Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription
SK Zaidi et al.
EMBO JOURNAL (2004)
WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus
A Komuro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases
VJ Bardou et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Cyclin D1, EMS1 and 11q13 amplification in breast cancer
CJ Ormandy et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
The cancer connection: BRCA1 and BRCA2 tumor suppression in mice and humans
ME Moynahan
ONCOGENE (2002)
Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-β/Smad signaling
O Ferrigno et al.
ONCOGENE (2002)
The human estrogen receptor-α is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators
AL Wijayaratne et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm
A Vassilev et al.
GENES & DEVELOPMENT (2001)
Physical interaction with Yes-associated protein enhances p73 transcriptional activity
S Strano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
